Maria Luisa Brandi ESA-SRB-NZSE-CaSR 2026 in conjunction with ENSA

Abstracts this author is presenting:

• The safety and efficacy of eneboparatide, a parathyroid hormone 1 receptor agonist, in adults with chronic hypoparathyroidism: a phase 3, randomized, placebo-controlled study (CALYPSO) — ESA - CaSR5 Joint Symposium | CaSR-5 Session 8: New therapies for hypoparathyroidism